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LARVICIDAL PERSISTENCE OF FORMULATIONS OF
BACILL(IS THURINGIENSIS VAR. ISRAELENSIS TO CONTROL
LARVAL AEDES AEGYPTI
PAULO T. R. VILARINHOS'AND ROSE MONNERAPs
ABSTRACT After detection of resistance to the organophosphate temephos in populations of Aedes aegypti
in Brazil, corncob granule (CG) and water-dispersible granule (WDG) formulations of Bacillus thuringiensis
yar. israelensis (Brj) were introduced in routine focal treatments. Larvicidal persistence and the influence of
exposure to sunlight on VectoBac@ formulations of Bti were compared in 250-liter fiberglass water containers.
Production of pupal Ae. aegypti in containers was used to indicate control. In untreated containers, survival of
larvae was always above 95Vo. A temephos sand glanule formulation used as reference treatment maintained
1007o control throughout the l2-wk period in all situations. Under sunlight exposure, control dropped below the
gOVo level in the 2nd week after treatment at both dosages of VectoBac CG (1 and 2 g/50 liters) and VectoBac
tablet (T) formulation at I tablet/lOo liters. VectoBac T at I tablet/50 liters provided 2 wk of 1007o control.
VectoBac WDG at dosages of 1 and 2 g/5OO liters provided 10070 control for 3 wk. Without sunlight exposure
(covered containers), VectoBac CG provided 9 wk of continuous l0o7o control and 5 wk of continuous 1007o
control, respectively, at I and 2 g/50 liters. The VectoBac T formulation at both dosages initially provided 2
wk of 1007o control. After this period, the control level fluctuated between 96 and 7OO7o. VectoBac WDG
provided continuous 1007o control for 7 wk for the lower dosage and for 6 wk for the higher dosage. At both
dosages of WDG, 1007o control was achieved in 11 wk out of the l2-wk period.
KEY WORDS Biological control, mosquito, entomopathogenic bacteria, sunlight exposure, containers
INTRODUCTION
Among the activities of dengue control pro-
grams, larval source reduction is the key to sus-
taining low densities of Aedes aegypti (L.), to re-
duce the risk of dengue epidemics. In this context,
larvicides are important for treating mosquito
breeding sites when immediate physical elimination
is not feasible, for instance in some water reservoirs
(PAHO 1994). Water storage is essential for many
communities in Brazil, mainly because of the ab-
sence of piped water in 25% of houses nationwide
and 35Vo of houses in the northeastern region(rBGE 2004).
The organophosphate temephos has low mam-
malian toxicity and good larvicidal persistence in
the sand granule formulation and has been widely
used in dengue control programs (Rozendaal 1997).
However, resistance to temephos has been detected
in populations of Ae. aegypti (Rawlins and Wan
1995, Macoris et al. 1999), leading to the imple-
mentation of alternative larvicides to avoid failures
in the field.
Such is the case in Brazil. where after the detec-
tion of resistance to temephos in populations of Ae.
aegypti, corncob granule (CG) and water-dispers-
ible granule (WDG) formulations of Bacillus thu-
ringiensis var. israelensis (Bti) were introduced in
routine focal treatments. For this purpose, the Bra-
zilian Health Foundation (FUNASA), in the ab-
I Diretoria de Vigil6ncia Ambiental, Brasilia, DE Bra-
zil.
2 Embrapa Recursos Gen6ticos e Biotecnologia CP
02372, Brasilia, DE Brazil.
3 To whom correspondence should be addressed.
sence of national commercial Brl production, has
imported hundreds of tons of 8rl (Vilarinhos 2002).
The aim of this work was to compare the per-
formance of 3 formulations of Bti in fiberglass wa-
ter reservoirs, to investigate larvicidal persistence
and the influence of exposure to sunlight.
MATERIALS AND METHODS
Fiberglass water containers (250-liter capacity)
were placed in an open area in 2 groups, 1 group
with lids covering just 507o of the container, allow-
ing direct sunlight to penetrate through the water
column, and another group with lids closed com-
pletely, blocking sunlight.
After filling the containers with chlorinated tap
water. treatments and untreated controls were made
in 3 replicates for both covered and uncovered con-
tainers. Products, formulations, and dosages are
given in Table 1. The treatment with the temephos
sand granule formulation routinely used by the Na-
tional Dengue Control Program (Fersol lG, 1 ppm)
was used as a treated control reference. The lower
Brl dosages of CG and WDG formulations tested
are those currently used in the National Dengue
Control Program. Water temperature in the contain-
ers was measured every 4 h with a 64-bit digital
temperature recorder.
Once a week, 40 early 3rd-instar laboratory-
reared Ae. aegypti were added to each container.
Although the larvae were fed (dog chow) during
initial stages at the laboratory, food was not added
after they were transferred to the containers, to sim-
ulate the conditions observed in the field. A sus-
ceptible strain, originally from the U.S. Department
of Agriculture laboratory at Gainesville, FL, was
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Thble 1' Potency, formulations, and dosages of Bacillus thuringiensis var. israelensis and temephos tested for
Jpersistence(fromCENARGEN/EMBRAPA,Brasf l ia,Df ;Brazi l ,2003) '
Product (potency) Formulation Dosage (ITU/liter)r
VectoBac T@
(2,2OO lTUlng)
VectoBac WDG
(3,000 ITU/mg)
VectoBac CG
(20O ITU/mg)
Fersol I G
Tablet
Water-di spersible granu le
Corn cob granule
Sand granule
Tl : I tablet/l0o liters (7,700)
T2 - | tablet/5O liters (15,400)
WDGI'  : I 9/500 liters (6,000)
WDG2 : 2 gl5OO liters (12,000)
CG1, : l g/50 liters (4,000)
CG22 : 2 g/50 liters (8,000)
I g/10 liters
rITU, intemational toxic units of Aedes aegypti.
l Cunent field dosage used by the Brazilian Health Foundation (FUNASA).
used because the influence of resistance to teme-
phos on persistence was not investigated in this
work.
Containers were checked daily for the production
of pupae. Pupae produced in the control and treated
containers were removed and counted, and the total
was recorded on a weekly basis. The percentage of
pupal production was used to evaluate the larvicidal
activity and the persistence of formulations. The
treatments were considered failed when the rate of
production of pupae was lOVo or higher.
The results were compared by using Kruskal-
Wallis l-way analysis of variance (ANOVA) on
ranks and Dunnett's method to compare with pro-
cedures from the Sigmastat computer program
(Kuo et al. 1992).
RESULTS AND DISCUSSION
Under sunlight exposure, none of the biological
products provided more than 4 wk of control (Fig.
l). VectoBac@ CG (Valent Biosciences Corpora-
tion, Libertyville, IL) at both dosages and the low-
er-dosage VectoBac tablet (T) formulation Tt
maintained the population under total control (with-
out pupae) for I wk. The control level dropped dur-
ing the 2nd week after treatment, resulting in more
than lOVo larval survival and pupal production. Sta-
tistical analysis of these 3 products in the 3nd week
did not show differences among the data (Fig. 1).
VectoBac T2 (higher dosage) provided 2 wk of
1007o control, although its effect began to decrease
in the 3rd week (4Vo of larvae survived to produce
pupae) until the 4th wk, where 257o of the exposed
population reached the pupal stage. The WDG at
both dosages provided 1007o control for 3 wk. Per-
sistence failed in the 4th week, allowing more than
lOTo of the larvae to become pupae. The statistical
analysis done with the number of pupae in the 4th
week showed no differences between the 2 dosages
of VectoBac WDG. However, a difference was
found between the 2 WDG treatments and
VectoBac T2 (Kruskal-Wallis l-way ANOVA, Il
: 5.793; df : 2; P : 0.05). According to these
results, Vectobac CG seems to be the most affected
by sunlight even though the potency of the CG2
formulation was higher than that of the lowest
WDG formulation (8,000 and 6,000 lTU/liter, re-
spectively). Examination of these data suggests that
features other than the active ingredient concentra-
tion play important roles in the larvicidal persis-
tence of Bri formulations. The longest larvicidal
persistence with sunlight that was obtained with
VectoBac WDG in both dosages sustains this hy-
pothesis. The results observed by Melo-Santos et
al. (2001) with an experimental tablet formulation
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Fig. t. Percentage of pupae produced during 4 wk of treatment with various formulations of biological products
under sunlight exposure (from EMBRAPA Recursos Gen6ticos e Biotecnologia, Brasflia, DR Brazil, 2003).
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Fig.2. Percentage of pupae produced during 12 wk of treatment with various formulations of biological products
without sunlight exposure (from EMBRAPA Recursos Gen6ticos e Biotecnologia, Brasilia, DE, Brazil, 2003).
from Far-Manguinhos (CP41) (Rio de Janeiro, RJ,
Brazil) in shaded and sunlight-exposed containers
are somewhat similar to the results obtained in the
present study. Melo-Santos et al. (2001) obtained 5
wk of 9OVo control in sunlight-exposed containers,
which is equal to our observations for the WDG
formulation at the high dosage. The persistence of
the tablet formulation VectoBac T under sunlight
was 3 wk shorter than that observed for CP41.
However, the potency of CP4l and data for dura-
tion of 1007o control in their work were not given.
All biological treatments maintained the popu-
lation under 9O7o of control during I I wk (Fig. 2)
without sunlight exposure (covered containers).
The data analysis did not show differences among
all treatments. VectoBac CG2 provided 9 wk of
continuous 1007o control at the higher dosage,
whereas the lower dosage provided 5 wk of contin-
uous 1007o control. After the 10th week, the results
were equal at both dosages. VectoBac T initially
provided 2 wk of IOOVo controL After this period,
the control level fluctuated between 96 and IOOVo
and both dosages achieved 1007o controls for 5 wk
out of the l2-wk period. VectoBac WDG provided
continuous control of lO}Vo for 7 wk for the lower
dosage and for 6 wk for the higher dosage. In both
dosages of WDG, 1007o control was achieved for
11 wk out of the 12-wk period.
In the covered containers, the persistence of all
Bri formulations was equivalent in this study and
longer than that observed for CP41, because in all
situations more than 9OVo control was obtained dur-
ing l1 wk. However, results with WDG were better,
because all treatments provided I I wk of IOOVo
control; the closest result to that level of control
was obtained with CG at the highest dosage for
9 wk.
Susceptibility of Bti to sunlight and ultraviolet
radiation is well documented (Ignoffo et al. 1982,
Becker et al. 1992, Liu et al. 1993, Myasnik et al.
2001). The results obtained in this study are in
agreement with those observations, because a no-
ticeable difference was found in the overall persis-
tence with exposure to sunlight, when compared to
treatments in covered containers. Similar with the
results of the present study, Chui et al. (1995), who
used higher concentrations of Vectobac CG and
4th-instar Ae. aegypti, observed a 76Vo decrease in
larval mortality after 8 days of exposure to a
14:10 h l ight:dark photoperiod.
Production of pupal Ae. aegypti in each control
container was never below 95Vo (data not shown).
Water temperature in the containers varied between
18.5 and 31.0"C in the uncovered containers (av-
erage 23.4oC) and 19.0 and 31.0'C in the covered
containers (average 22.5"C). The organophosphate
temephos sand granule formulation (Fersol 1G)
maintained 1007o control throughout the 12-wk pe-
riod in both situations (data not shown).
Considering the 6o-day cycle of visits employed
by the National Dengue Control Program in Brazil,
examination of the results of this study suggests
that the WDG formulation of VectoBac is more
suitable than the other formulations for routine
treatments in drinking water containers.
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